Adams Brian (CIK 0001636994)

Latest company ownership

Role: Chief Legal Officer
Shares held
371,472
Last filed at
Jul 30, 2025
Confidence Score
49.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 28, 2025 Jul 30, 2025 Relay Therapeutics, Inc. Chief Legal Officer Sell 42.5 -19,913 -5.09% $73.4K
Apr 28, 2025 Apr 30, 2025 Relay Therapeutics, Inc. Chief Legal Officer Sell 46.3 -14,587 -3.59% $44K
Mar 27, 2025 Mar 31, 2025 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -298 -0.07% $846.3
Jan 28, 2025 Jan 30, 2025 Relay Therapeutics, Inc. Chief Legal Officer Sell 95.0 +84,662 26.32% $247.9K
Dec 27, 2024 Dec 31, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -299 -0.09% $1.3K
Oct 28, 2024 Oct 30, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 50.0 -1,632 -0.50% $9.9K
Sep 27, 2024 Oct 1, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -295 -0.09% $2.2K
Jul 29, 2024 Jul 31, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 48.8 -1,638 -0.50% $14.5K
Jun 27, 2024 Jul 1, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -295 -0.09% $1.8K
Apr 29, 2024 Apr 29, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 51.3 -1,623 -0.50% $10.4K
Mar 27, 2024 Mar 29, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -348 -0.11% $2.7K
Jan 29, 2024 Jan 31, 2024 Relay Therapeutics, Inc. Chief Legal Officer Sell 48.8 -1,929 -0.59% $18.6K
Dec 27, 2023 Dec 29, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -294 -0.23% $3.4K
Oct 30, 2023 Nov 1, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 47.5 -1,632 -1.24% $9.8K
Sep 27, 2023 Sep 29, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -294 -0.22% $2.5K
Jul 28, 2023 Jul 31, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 46.3 -1,628 -1.22% $19.2K
Jun 27, 2023 Jun 28, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -294 -0.22% $3.6K
Apr 28, 2023 Jun 1, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 46.3 -1,936 -1.43% $21.6K
Apr 28, 2023 May 1, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 50.0 -863 -0.64% $9.6K
Mar 27, 2023 Mar 28, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -347 -0.25% $5.3K
Jan 30, 2023 Jan 31, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 48.8 -864 -0.63% $18.6K
Jan 12, 2023 Jan 13, 2023 Relay Therapeutics, Inc. Chief Legal Officer Sell 20.0 -9,994 -16.24% $199.9K
Dec 27, 2022 Dec 28, 2022 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -295 -0.48% $4.3K
Oct 28, 2022 Nov 1, 2022 Relay Therapeutics, Inc. Chief Legal Officer Sell 46.3 -728 -1.16% $15.7K
Sep 27, 2022 Sep 29, 2022 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -294 -0.47% $6.7K
Jul 28, 2022 Jul 29, 2022 Relay Therapeutics, Inc. Chief Legal Officer Sell 46.3 -734 -1.15% $15.6K
Jun 27, 2022 Jun 28, 2022 Relay Therapeutics, Inc. Chief Legal Officer Sell 52.5 -300 -0.47% $6.1K
Apr 28, 2022 May 2, 2022 Relay Therapeutics, Inc. Chief Legal Officer Sell 46.3 -708 -1.10% $18.1K
Mar 29, 2022 Mar 31, 2022 Relay Therapeutics, Inc. Chief Legal Officer Sell 50.0 -333 -0.51% $9.9K
Dec 27, 2021 Dec 27, 2021 Relay Therapeutics, Inc. General Counsel Sell 47.5 -295 -1.17% $9.8K
Nov 15, 2021 Nov 16, 2021 Relay Therapeutics, Inc. General Counsel Sell 15.0 -6,500 -20.45% $230.2K
Sep 27, 2021 Sep 27, 2021 Relay Therapeutics, Inc. General Counsel Sell 46.3 -293 -1.15% $10.8K
Sep 13, 2021 Sep 13, 2021 Relay Therapeutics, Inc. General Counsel Sell 15.0 -6,500 -20.26% $227.6K
Jun 28, 2021 Jun 30, 2021 Relay Therapeutics, Inc. General Counsel Sell 46.3 -293 -1.13% $10.5K
Jun 7, 2021 Jun 9, 2021 Relay Therapeutics, Inc. General Counsel Sell 15.0 -6,500 -20.08% $227.5K
Apr 26, 2021 Apr 28, 2021 Relay Therapeutics, Inc. General Counsel Sell 15.0 -6,500 -20.08% $227.5K
Jan 28, 2021 Jan 29, 2021 Relay Therapeutics, Inc. General Counsel Sell 20.0 -5,000 -33.33% $275.3K
Jul 20, 2020 Jul 21, 2020 Relay Therapeutics, Inc. General Counsel Buy 95.0 +10,000 100.00% $200K